Chin Eric 4

What Happened Eric Chin, a director of Biomerica, Inc. (BMRA), was awarded 22,500 restricted shares on December 12, 2025. The shares were granted at $0.00 per share (award/ acquisition) — recorded value $0 on the Form 4 — and are reported as an A (award/grant) transaction rather than an open-market purchase.

Key Details

• Transaction date: 2025-12-12; reported on Form 4 filed 2026-01-28 (filing appears late).
• Transaction type/code: A — Award of restricted stock; price per share reported $0.00.
• Shares involved: 22,500 restricted shares granted; recorded total value $0 on the form.
• Shares owned after transaction: Not stated in the provided filing.
• Footnote: Award vests in full on the one-year anniversary (Dec 12, 2026) if Chin remains in continuous service, with possible accelerated vesting on certain change-of-control events.
• Timeliness: The Form 4 was filed on 2026-01-28 for a 2025-12-12 grant (late filing), which is disclosure-timing risk but does not change the nature of the award.

Context Restricted stock awards to directors are common forms of compensation and do not involve an outright cash purchase; they typically align compensation with long-term shareholder value. Because these shares are subject to vesting and service conditions, they are not immediately liquid and do not necessarily signal a near-term trading intent.